NorthWest Biotherapeutics Inc (NWBO)

[Mike238191]

I listened to the whole thing. My takeaways:

1.) Stopped taking new patients in 2008 for financial reasons
2.) Linda is disappointed with the overall curve (looking at 2 year stale data) but she is optimistic about the tail of long term survival.
3.) data locked a month ago, she is “anxiously awaiting data”.
4.) She said that it was the company’s decision not to unblind the data 2 years ago (and in my opinion she sounded slightly annoyed)
5.) I’m guessing it’s some rule, but I noticed that she actively avoided saying the name of the company.
6.) I saw the 47% 3yr number, but that wasn’t the new data. That was something we’ve seen before, and I’m not sure what it was referring to.
7.) Linda believes that glioblastoma is not one disease. It’s several. And she seemed to infer that the trial might only be successful for a few of them.

Overall this was neutral in my view.